theMednetRegister

Cardiology

Diabetes   

Questions discussed in this category

How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?
2 Answers available
How should clinicians balance the use of finerenone with other heart failure treatments like SGLT2 inhibitors, considering their glycemic benefits?
Butt et al., PMID 39818225
2 Answers available
What is the optimal BP target for patients with diabetes and hypertension to reduce their risk of MI/stroke?
2 Answers available
Do you favor Sotagliflozin over SGLT2i alone for cardiovascular risk reduction in patients with Type 2 diabetes and chronic kidney disease?
1 Answer available
Besides treadmill, what other exercises may be considered for post-exercise ABIs, and are their diagnostic parameters identical to standard post-exercise ABIs?
1 Answer available
Are recurrent UTIs a contraindication to SGLT2i use?
4 Answers available
Should we be more cautious with the use of GLP 1 R agonist therapy in patients with Type 1 diabetes mellitus and obesity given the increased risk of cardiovascular disease with high body weight variability?
Prattichizzo et al., PMID 39468384
1 Answer available
Would you recommend statin initiation in a young adult patient (age < 40) with type 1 diabetes mellitus and LDL cholesterol levels greater than 100 without any cardiovascular risk factors?
1 Answer available
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Butler et al., PMID 38587237
1 Answer available
Do you recommend adding low-dose Aspirin for primary prevention in patients with Type 2 Diabetes on Eliquis for another indication?
1 Answer available
Does oral semaglutide provide similar cardiovascular risk reduction benefits as injectable semaglutide?
1 Answer available
How do the results of the ESPRIT trial, which evaluated the impact of an SBP target of <120 mmHg on preventing major cardiovascular events, influence your blood pressure management goals for hypertensive patients with diabetes or a history of stroke?
ESPRIT Trial
1 Answer available
When do you recommend screening patients with T2DM for heart failure?
2 Answers available
Is ABI (Ankle Brachial index) lower limb arterial doppler not recommended if patient already has arterial stents in the legs, and if so, what other imaging modality would you consider as first-line?
1 Answer available


Papers discussed in this category

The New England journal of medicine, 2024 Apr 06
Empagliflozin after Acute Myocardial Infarction.
Lancet (London, England), 2024 Jun 27
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
The New England journal of medicine, 2016 Sep 15
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
The New England journal of medicine, 2023 Nov 11
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med, 2015 Nov 09
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
Diabetes care, 2025 Jan 01
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025.
The New England journal of medicine, 2024 Nov 16
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
European heart journal, 2016-07-14
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
The New England journal of medicine, 2024 Sep 01
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
Circulation, 2024 Sep 28
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.
The lancet. Diabetes & endocrinology, 2025 Feb 13
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial.

Related Topics in Cardiology

Copyright © 2025 theMednet
All Rights Reserved.